Skip to main content
TipRanks
Go Ultimate75% OFF

Julie Papanek Grant Insider Profile

4 Followers

Julie Papanek Grant, former Director at Day One Biopharmaceuticals, holds 2.88M shares in Day One Biopharmaceuticals (Ticker: DAWN).

Julie Papanek Grant's Trading History

DAWN
Day One Biopharmaceuticals
Mar 03, 2023―Uninformative Sell465.25K$62.02M
DAWN
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Mar 03, 2023Uninformative Sell$465.25K25,000$18.61―
Feb 03, 2023Uninformative Sell$530.77K25,000$21.23―
Jan 04, 2023Uninformative Sell$516.06K25,000$20.64―
Dec 12, 2022Uninformative Sell$96.18K4,358$22.07―
Dec 05, 2022Uninformative Sell$216.45K10,000$21.64―

You May Also Like

Julie Papanek Grant insider profile FAQ

What is the percentage of profitable transactions made by Julie Papanek Grant?
The percentage of profitable transactions made by Julie Papanek Grant is 75%.
What is the average return per transaction made by Julie Papanek Grant?
The average return per transaction made by Julie Papanek Grant is 6.60%.
What stocks does Julie Papanek Grant hold?
Julie Papanek Grant holds: DAWN stocks.
What was Julie Papanek Grant’s latest transaction?
Julie Papanek Grant’s latest transaction was an Uninformative Sell of $465.25K.
What was Julie Papanek Grant's most profitable transaction?
Julie Papanek Grant’s most profitable transaction was an Informative Sell of DAWN stock on September 15, 2022. The return on the trade was 38.80%.
What is Julie Papanek Grant's role in Day One Biopharmaceuticals?
Julie Papanek Grant's role in Day One Biopharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.